Shin-Cheng Tzeng (Newcity)

Shin-Cheng (Newcity) Tzeng currently serves as a Principal Scientist at C2N Diagnostics, a position held since March 2023. Previously, Shin-Cheng was a Senior Staff Scientist at the Donald Danforth Plant Science Center from August 2016 to March 2023, where notable work included the discovery of novel peptide antigens for cancer therapy and diagnostics, set to be published in Nature Genetics. Earlier experience includes roles as a Staff Scientist, where significant advancements were made in protein quantification methods, and as a Postdoctoral Research Associate at Washington University School of Medicine, contributing to publications in Nature Communications. Shin-Cheng's academic background includes a Ph.D. in Analytical Chemistry from Oregon State University, complemented by Master's and Bachelor's degrees in Food Science from National Taiwan Ocean University.